Age-adjusted Charlson comorbidity index in recurrent glioblastoma: a new prognostic factor?

BACKGROUND: For recurrent glioblastoma (GB) patients, several therapy options have been established over the last years such as more aggressive surgery, re-irradiation or chemotherapy. Age and the Karnofsky Performance Status Scale (KPSS) are used to make decisions for these patients as these are es...

Descripción completa

Detalles Bibliográficos
Autores principales: Barz, Melanie, Bette, Stefanie, Janssen, Insa, Aftahy, A. Kaywan, Huber, Thomas, Liesche-Starnecker, Friederike, Ryang, Yu-Mi, Wiestler, Benedikt, Combs, Stephanie E., Meyer, Bernhard, Gempt, Jens
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2022
Materias:
Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8780246/
https://www.ncbi.nlm.nih.gov/pubmed/35062885
http://dx.doi.org/10.1186/s12883-021-02532-x

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8780246/
https://www.ncbi.nlm.nih.gov/pubmed/35062885
http://dx.doi.org/10.1186/s12883-021-02532-x

Ejemplares similares